Recientemente Albian Group ha conseguido marcar un nuevo hito en su trayectoria pues nos ha sido encomendado nuestro primer proyecto en China.
Read moreThe European Medicines Agency Network Strategy to 2025 was detailed just last week during the 20th Regulatory Affairs and Pharmacovigilance conference.
Read moreNuestros expertos Vicente Tur, Regulatory Affairs Director y Ramón Hernández Moratinos, Senior Regulatory Information Specialist, junto a Ana Viñas, Técnico de la AEMPS serán ponentes en el curso...
Read moreThe 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.
Read moreProviding guidance about Regulatory Affairs and Trade changes in the Pharma and Medical Devices industries
Read more GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respe...
Read moreEn este informe se destaca el alto nivel de empleo del sector de tecnologías sanitarias
Read moreStrong public-private collaboration in the research environment requires that health research institutions, through their transfer offices, offer an attractive portfolio of projects to the private sec...
Read moreNowadays there are international standards that are easily recognisable and accepted by all, which makes it much easier to close transactions regardless of the origin of the investor, especially in th...
Read moreComo anticipo al nuevo Real Decreto de productos sanitarios y el establecimiento del Registro de Comercialización la AEMPS pone en marcha esta nueva versión de RPS mejorada. Cualquier empresa establ...
Read moreGENESIS Biomed has collaborated in the creation of many start-ups and spin-offs and at the beginning of the year 2022 we would like to mention all of these that, thanks to courageous researchers/entre...
Read more